A vial of the AstraZeneca vaccine is seen at a COVID-19 vaccination centre in the Odeon Luxe Cinema in Maidstone, Britain February 10, 2021. REUTERS/Andrew Couldridge
JOHANNESBURG (Reuters) - The African Union's disease control body said on Thursday that it was not "walking away" from AstraZeneca's COVID-19 vaccine, after trial data showed it had greatly reduced efficacy against the coronavirus variant dominant in South Africa.
African countries are due to receive 100 million doses of the AstraZeneca shot this year under an AU vaccine plan.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
